Wyeth News
Most Popular Wyeth Story
Pfizer to chop up to $3B from R&D budget
Signaling that Pfizer's "monolithic" approach to drug R&D is over, CEO Jeffrey Kindler laid out plans to carve $3 billion out of the newly merged company's budget for R&D as the pharma giant... Read more...
Latest Headlines
- February 4, 2010
- February 1, 2010
- November 10, 2009
- October 15, 2009
- October 14, 2009
- September 18, 2009
- August 12, 2009
- June 30, 2009
- June 26, 2009
- April 2, 2009
- March 23, 2009
- March 18, 2009
- January 28, 2009
- January 26, 2009
- January 23, 2009
- January 12, 2009
- January 8, 2009
- January 7, 2009
- December 18, 2008
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
